arrow
E

Elizabeth S. Frank

Harvard University
H指数:21
被引数:2,660

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast cancer survivors
2023-03-010
PRE
Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial
2022-05-0111
OA
The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention

乳腺癌减肥试验 (Alliance A011401): 生活方式干预的描述和证据

OBESITY
IF4.7
2021-12-2112
OAAI
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer
2021-04-077
OAAI
The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions
2020-02-150
PRE
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia
2020-02-0531
OAAI
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
2019-02-1567
OAAI
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design
2017-09-2177
OAAI